$BIIB Headlines One lesson for investors from
Post# of 44957
Posted On: 06/30/2014 1:31:38 PM
$BIIB Headlines
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:44 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:22 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:18 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
3 Stocks Underperforming Today In The Drugs Industry 27 min ago - TheStreet.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. Today - Zacks.com
Celladon Corporation (CLDN) Jumps: Stock Rises 5.3% - Tale of the Tape 9:21 a.m. Today - Zacks.com
Discovery Laboratories Inc. (DSCO) in Focus: Stock Rises 7.83% - Tale of the Tape 8:44 a.m. Today - Zacks.com
BioDelivery Progresses with Clonidine Late-Stage Study - Analyst Blog 6:00 p.m. June 27, 2014 - Zacks.com
Coronado Falls on TSO Study Results - Analyst Blog 11:20 a.m. June 27, 2014 - Zacks.com
Auxilium/Sobi's Xiapex Filed for Label Expansion - Analyst Blog 5:00 p.m. June 26, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PCRX ISRG SHPG BIIB 2:15 p.m. June 26, 2014 - InvestorPlace.com
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine! 11:17 a.m. June 26, 2014 - Seeking Alpha
Bristol-Myers Up on Nivolumab News - Analyst Blog 10:45 a.m. June 26, 2014 - Zacks.com
Prothena Corporation (PRTA) Falls: Stock Goes Down 5.3% - Tale of the Tape 8:43 a.m. June 26, 2014 - Zacks.com
Isis Pharma Gets $1M Milestone Payment from Glaxo - Analyst Blog 6:10 p.m. June 25, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
AbbVie Sets Rationale for Shire Bid 1:06 p.m. June 25, 2014 - The Wall Street Journal Interactive Edition
British Columbia to Reimburse TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis 11:00 a.m. June 25, 2014 - CNW Group
XenoPort's XP23829 in Phase II Study - Analyst Blog 4:52 p.m. June 24, 2014 - Zacks.com
Insider Trading Alert - BIIB, FDS And GCO Traded By Insiders 10:45 a.m. June 24, 2014 - TheStreet.com
Stocks with Upgraded Broker Ratings - Screen of the Week 4:05 a.m. June 24, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, BMY, BIIB 4:29 p.m. June 23, 2014 - TheStreet.com
AbbVie, Shire Give Bullish Guidance Amid Buyout Talk 10:24 a.m. June 23, 2014 - Investors Business Daily
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:55 p.m. June 6, 2014 - BusinessWire - BZX
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:46 p.m. June 6, 2014 - BusinessWire - BZX
Human Metabolome Technologies, Inc., (HMT) Hires Alexander Buko Ph.D. as Vice President, Business and Product Development and Releases a New C13 Flux Analysis Service, F-SCOPE. 3:27 p.m. June 6, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Critical Alerts For Tesla, Apple, Ryder System, ExOne, and Biogen Idec Released By InvestorsObserver 9:31 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Alexandria Real Estate Equities, Inc. Receives LEED Gold Certification for Biogen Idec Inc.'s Build-to-Suit Headquarters in Cambridge, Massachusetts 8:30 a.m. June 2, 2014 - PR Newswire - PRF
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses 7:30 a.m. May 30, 2014 - BusinessWire - BZX
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:44 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:22 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:18 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
3 Stocks Underperforming Today In The Drugs Industry 27 min ago - TheStreet.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. Today - Zacks.com
Celladon Corporation (CLDN) Jumps: Stock Rises 5.3% - Tale of the Tape 9:21 a.m. Today - Zacks.com
Discovery Laboratories Inc. (DSCO) in Focus: Stock Rises 7.83% - Tale of the Tape 8:44 a.m. Today - Zacks.com
BioDelivery Progresses with Clonidine Late-Stage Study - Analyst Blog 6:00 p.m. June 27, 2014 - Zacks.com
Coronado Falls on TSO Study Results - Analyst Blog 11:20 a.m. June 27, 2014 - Zacks.com
Auxilium/Sobi's Xiapex Filed for Label Expansion - Analyst Blog 5:00 p.m. June 26, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PCRX ISRG SHPG BIIB 2:15 p.m. June 26, 2014 - InvestorPlace.com
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine! 11:17 a.m. June 26, 2014 - Seeking Alpha
Bristol-Myers Up on Nivolumab News - Analyst Blog 10:45 a.m. June 26, 2014 - Zacks.com
Prothena Corporation (PRTA) Falls: Stock Goes Down 5.3% - Tale of the Tape 8:43 a.m. June 26, 2014 - Zacks.com
Isis Pharma Gets $1M Milestone Payment from Glaxo - Analyst Blog 6:10 p.m. June 25, 2014 - Zacks.com
Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog 4:30 p.m. June 25, 2014 - Zacks.com
AbbVie Sets Rationale for Shire Bid 1:06 p.m. June 25, 2014 - The Wall Street Journal Interactive Edition
British Columbia to Reimburse TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis 11:00 a.m. June 25, 2014 - CNW Group
XenoPort's XP23829 in Phase II Study - Analyst Blog 4:52 p.m. June 24, 2014 - Zacks.com
Insider Trading Alert - BIIB, FDS And GCO Traded By Insiders 10:45 a.m. June 24, 2014 - TheStreet.com
Stocks with Upgraded Broker Ratings - Screen of the Week 4:05 a.m. June 24, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, BMY, BIIB 4:29 p.m. June 23, 2014 - TheStreet.com
AbbVie, Shire Give Bullish Guidance Amid Buyout Talk 10:24 a.m. June 23, 2014 - Investors Business Daily
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration agreement with Biogen Idec 2:01 a.m. June 16, 2014 - Thomson Reuters ONE
One Year Post-Launch, All Surveyed U.S. Neurologists Report Having Clinical Experience with Biogen Idec's Tecfidera for the Treatment of Multiple Sclerosis 12:00 p.m. June 12, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology 5:00 a.m. June 11, 2014 - BusinessWire - BZX
The Pulmonary Fibrosis Foundation Receives Grant From Biogen Idec To Support The PFF Patient Registry 11:00 a.m. June 10, 2014 - PR Newswire - PRF
Increased Credit Facility Commitments, Positions Moved, Survey Results, LEED Certification, and New Board Member Election - Analyst Notes on Prospect, Waddell & Reed, SEI, Alexandria and RPAI 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1 7:00 a.m. June 9, 2014 - PR Newswire - PRF
The US Food and Drug Administration (FDA) approves Eloctate(TM) 2:02 a.m. June 9, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:55 p.m. June 6, 2014 - BusinessWire - BZX
FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children 4:46 p.m. June 6, 2014 - BusinessWire - BZX
Human Metabolome Technologies, Inc., (HMT) Hires Alexander Buko Ph.D. as Vice President, Business and Product Development and Releases a New C13 Flux Analysis Service, F-SCOPE. 3:27 p.m. June 6, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis 8:30 a.m. June 5, 2014 - PR Newswire - PRF
Critical Alerts For Tesla, Apple, Ryder System, ExOne, and Biogen Idec Released By InvestorsObserver 9:31 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Alexandria Real Estate Equities, Inc. Receives LEED Gold Certification for Biogen Idec Inc.'s Build-to-Suit Headquarters in Cambridge, Massachusetts 8:30 a.m. June 2, 2014 - PR Newswire - PRF
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses 7:30 a.m. May 30, 2014 - BusinessWire - BZX
(0)
(0)